Viewing Study NCT06603051



Ignite Creation Date: 2024-10-26 @ 3:40 PM
Last Modification Date: 2024-10-26 @ 3:40 PM
Study NCT ID: NCT06603051
Status: NOT_YET_RECRUITING
Last Update Posted: None
First Post: 2024-09-10

Brief Title: The Effect of Pre-Operative Cryoneurolysis on Post-Operative Narcotic Consumption in Patients Undergoing Autograft ACL Reconstruction
Sponsor: None
Organization: None

Study Overview

Official Title: The Effect of Pre-Operative Cryoneurolysis on Post-Operative Narcotic Consumption in Patients Undergoing Autograft ACL Reconstruction
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of the research is to investigate the effect of preoperative Cryoneurolysis of the knee on postoperative pain management in patients undergoing autograft anterior cruciate ligament ACL reconstruction a surgical procedure that makes a new ACL using the patients own tendon Cryoneurolysis is an approved process of applying extreme cold temperatures to targeted nerves in order to decrease or eliminate pain If you take part in the research you will be randomly assigned assigned by chance like a flip of a coin to Group A standard care or Group B standard care plus Cryoneurolysis Participants in both groups will undergo standard ACL reconstruction and receive standard preoperative and postoperative pain management Participants in Group B only will also receive a standard treatment of Cryoneurolysis to their surgical knee within 7-10 days before their scheduled surgery Participants in both groups A amp B will be asked to bring their remaining postoperative pain medication to their postoperative follow-up appointments for review by study personnel Participants will also be asked to complete a survey about their knee activity function and symptoms at these appointments Your time in the study will last until the completion of the 12-week postoperative follow-up appointment
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None